Use of mesenchymal cells for the treatment of patients with respiratory syndrome caused by new coronavirus : Use of mesenchymal cells for the treatment of patients with severe acute respiratory syndrome caused by SARS-CoV-2

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 29. Mai Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: COVID-19-associated acute respiratory distress syndrome;A00-B99
Recruitment Status: Completed
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 31-08-2020, Last updated: 2023-06-05

ICTRP ID:

RBR-3fz9yr

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO007379714